Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Johnson & Johnson joins WHO to prevent spread of Ebola in West Africa » 08:06
05/13/21
05/13
08:06
05/13/21
08:06
JNJ

Johnson & Johnson

$168.21 /

-0.62 (-0.37%)

Johnson & Johnson…

Johnson & Johnson announced the World Health Organization and the government of Sierra Leone have begun administering the company's Ebola vaccine regimen as part of a WHO early access clinical program aimed at preventing further spread of Ebola in West Africa. The vaccine regimen, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson in collaboration with Bavarian Nordic A/S, is being donated to the WHO by Janssen for the purposes of the early access clinical program. Johnson & Johnson also announced that its Ebola vaccine regimen has received Prequalification from the WHO, which will help accelerate its registration in countries where Ebola is a persistent public health threat and facilitate broader access to people at risk of exposure to this virus.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

Periodicals
CDC confirms 28 cases of rare disorder linked to J&J vaccine, NY Times reports » 06:13
05/13/21
05/13
06:13
05/13/21
06:13
JNJ

Johnson & Johnson

$168.21 /

-0.62 (-0.37%)

The Centers for Disease…

The Centers for Disease Control and Prevention confirmed a total of 28 cases, including 6 men, who have developed the rare blood clotting disorder after receiving the Johnson & Johnson COVID-19 vaccine, Emily Anthes of The New York Times reports, citing a meeting at the C.D.C. All cases involve adults and women appear to continue to be at an elevated risk of developing the disorder compared to men. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

Tuesday
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:57
05/11/21
05/11
16:57
05/11/21
16:57
PFE

Pfizer

$39.34 /

-0.53 (-1.33%)

, BNTX

BioNTech

$198.60 /

-3.93 (-1.94%)

, JNJ

Johnson & Johnson

$168.82 /

-1.62 (-0.95%)

, UFS

Domtar

$55.41 /

+8.01 (+16.90%)

, LB

L Brands

$67.58 /

-1.24 (-1.80%)

, SRNG

Soaring Eagle Acquisition

$9.87 /

-0.08 (-0.80%)

, WYNN

Wynn Resorts

$124.95 /

-0.76 (-0.60%)

, AUS

Austerlitz Acquisition Corporation I

$9.88 /

-0.03 (-0.30%)

, PLTR

Palantir

$20.21 /

+1.74 (+9.42%)

, SPCE

Virgin Galactic

$18.12 /

+0.15 (+0.83%)

, FOE

Ferro

$21.75 /

+4.1 (+23.23%)

, DDD

3D Systems

$24.02 /

+6.21 (+34.87%)

, NLOK

NortonLifeLock

$23.35 /

+2.27 (+10.77%)

, NNOX

Nano-X Imaging

$21.29 /

-4.87 (-18.62%)

, REAL

RealReal

$16.43 /

-3.8599 (-19.02%)

, RXT

Rackspace Technology

$19.02 /

-5.05 (-20.98%)

, REKR

Rekor Systems

$11.30 /

-2.43 (-17.70%)

, RBLX

Roblox

$77.76 /

+13.45 (+20.91%)

The major averages had a…

ShowHide Related Items >><<
WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

UFS Domtar
$55.41 /

+8.01 (+16.90%)

SRNG Soaring Eagle Acquisition
$9.87 /

-0.08 (-0.80%)

SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

REKR Rekor Systems
$11.30 /

-2.43 (-17.70%)

REAL RealReal
$16.43 /

-3.8599 (-19.02%)

RBLX Roblox
$77.76 /

+13.45 (+20.91%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

NNOX Nano-X Imaging
$21.29 /

-4.87 (-18.62%)

NLOK NortonLifeLock
$23.35 /

+2.27 (+10.77%)

LB L Brands
$67.58 /

-1.24 (-1.80%)

JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

FOE Ferro
$21.75 /

+4.1 (+23.23%)

DDD 3D Systems
$24.02 /

+6.21 (+34.87%)

BNTX BioNTech
$198.60 /

-3.93 (-1.94%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
BNTX BioNTech
$198.60 /

-3.93 (-1.94%)

05/11/21
Fly Intel: Top five analyst downgrades
05/11/21 Bryan Garnier
BioNTech downgraded to Neutral from Buy at Bryan Garnier
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
UFS Domtar
$55.41 /

+8.01 (+16.90%)

05/07/21 RBC Capital
Domtar price target raised to $43 from $40 at RBC Capital
05/07/21 BMO Capital
Domtar price target raised to $53 from $40 at BMO Capital
01/20/21 BofA
Domtar upgraded to Buy from Neutral at BofA
01/20/21 BofA
Domtar upgraded to Buy from Neutral at BofA
LB L Brands
$67.58 /

-1.24 (-1.80%)

05/12/21 RBC Capital
L Brands price target raised to $70 from $65 at RBC Capital
05/12/21 Deutsche Bank
L Brands price target raised to $87 from $80 at Deutsche Bank
05/12/21 Citi
L Brands price target raised to $70 from $62 at Citi
05/11/21 JPMorgan
L Brands price target raised to $93 from $88 at JPMorgan
SRNG Soaring Eagle Acquisition
$9.87 /

-0.08 (-0.80%)

WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
AUS Austerlitz Acquisition Corporation I
$9.88 /

-0.03 (-0.30%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

05/12/21 Wolfe Research
Palantir price target lowered to $20 from $23 at Wolfe Research
05/12/21 Morgan Stanley
Palantir building toward more durable growth, but priced in, says Morgan Stanley
05/12/21 Goldman Sachs
Goldman 'encouraged' by 'noteworthy' Q1 from Palantir, keeps Buy
05/12/21 Citi
Palantir price target raised to $17 from $15 at Citi
SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

05/11/21 Credit Suisse
Virgin Galactic price target lowered to $33 from $42 at Credit Suisse
05/11/21 Susquehanna
Virgin Galactic price target lowered to $20 from $34 at Susquehanna
04/12/21 Bernstein
Virgin Galactic initiated with a Market Perform at Bernstein
03/16/21 Truist
Truist starts 'uniquely positioned' Virgin Galactic at Buy with $50 price target
FOE Ferro
$21.75 /

+4.1 (+23.23%)

05/12/21 Gabelli
Ferro downgraded to Sell from Buy at Gabelli
05/12/21 Deutsche Bank
Ferro downgraded on 'fair but not full' buyout price at Deutsche Bank
05/12/21 JPMorgan
Ferro downgraded to Underweight from Neutral at JPMorgan
05/11/21 Deutsche Bank
Ferro downgraded to Hold from Buy at Deutsche Bank
DDD 3D Systems
$24.02 /

+6.21 (+34.87%)

05/12/21 B. Riley
3D Systems price target raised to $26 from $25 at B. Riley
05/12/21 Loop Capital
3D Systems price target lowered to $24 from $31 at Loop Capital
05/11/21 Craig-Hallum
3D Systems upgraded to Buy on valuation at Craig-Hallum
05/11/21 Craig-Hallum
3D Systems upgraded to Buy from Hold at Craig-Hallum
NLOK NortonLifeLock
$23.35 /

+2.27 (+10.77%)

05/12/21 BofA
NortonLifeLock double-upgraded to Buy from Underperform at BofA
05/11/21 Barclays
NortonLifeLock price target raised to $31 from $27 at Barclays
04/13/21 BofA
NortonLifeLock initiated with an Underperform at BofA
03/15/21 Credit Suisse
NortonLifeLock assumed with a Neutral at Credit Suisse
NNOX Nano-X Imaging
$21.29 /

-4.87 (-18.62%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
09/15/20 Cantor Fitzgerald
Cantor reiterates $70 target on Nano-X after 'unfounded' short report
REAL RealReal
$16.43 /

-3.8599 (-19.02%)

05/11/21 BTIG
RealReal downgraded to Neutral from Buy at BTIG
05/11/21 BTIG
RealReal downgraded to Neutral from Buy at BTIG
05/04/21 Piper Sandler
Piper Sandler a buyer of RealReal into the Q1 results
04/13/21 KeyBanc
eBay's watch selling fee increase 'favorable' for RealReal, says KeyBanc
RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

05/12/21 Raymond James
Rackspace Technology upgraded to Strong Buy from Outperform at Raymond James
05/12/21 Raymond James
Rackspace upgraded to Strong Buy from Outperform at Raymond James
04/19/21 Raymond James
Rackspace Technology initiated with an Outperform at Raymond James
04/19/21 Raymond James
Rackspace Technology initiated with an Outperform at Raymond James
REKR Rekor Systems
$11.30 /

-2.43 (-17.70%)

05/11/21 B. Riley
Rekor Systems price target lowered to $17.50 from $26 at B. Riley
04/19/21 Northland
Rekor Systems price target raised to $26 from $24 at Northland
03/11/21 Lake Street
Lake Street 'encouraged' by Rekor Systems' UVED and Mastercard progress
03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
RBLX Roblox
$77.76 /

+13.45 (+20.91%)

05/11/21 Truist
Roblox price target raised to $83 from $78 at Truist
05/11/21 Morgan Stanley
Roblox price target raised to $87 from $80 at Morgan Stanley
05/07/21
Fly Intel: Top five analyst initiations
05/07/21 LightShed Partners
LightShed Partners starts Roblox at Buy with $85 price target
WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

UFS Domtar
$55.41 /

+8.01 (+16.90%)

SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

REKR Rekor Systems
$11.30 /

-2.43 (-17.70%)

REAL RealReal
$16.43 /

-3.8599 (-19.02%)

RBLX Roblox
$77.76 /

+13.45 (+20.91%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

NNOX Nano-X Imaging
$21.29 /

-4.87 (-18.62%)

NLOK NortonLifeLock
$23.35 /

+2.27 (+10.77%)

LB L Brands
$67.58 /

-1.24 (-1.80%)

JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

FOE Ferro
$21.75 /

+4.1 (+23.23%)

DDD 3D Systems
$24.02 /

+6.21 (+34.87%)

BNTX BioNTech
$198.60 /

-3.93 (-1.94%)

  • 11
    Feb
  • 09
    Feb
  • 05
    Feb
  • 21
    Aug
  • 06
    Aug
  • 05
    Aug
  • 23
    Jul
  • 03
    Jun
  • 20
    May
WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

UFS Domtar
$55.41 /

+8.01 (+16.90%)

SRNG Soaring Eagle Acquisition
$9.87 /

-0.08 (-0.80%)

SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

REKR Rekor Systems
$11.30 /

-2.43 (-17.70%)

RBLX Roblox
$77.76 /

+13.45 (+20.91%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

NLOK NortonLifeLock
$23.35 /

+2.27 (+10.77%)

LB L Brands
$67.58 /

-1.24 (-1.80%)

JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

BNTX BioNTech
$198.60 /

-3.93 (-1.94%)

WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

UFS Domtar
$55.41 /

+8.01 (+16.90%)

SRNG Soaring Eagle Acquisition
$9.87 /

-0.08 (-0.80%)

SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

REKR Rekor Systems
$11.30 /

-2.43 (-17.70%)

REAL RealReal
$16.43 /

-3.8599 (-19.02%)

RBLX Roblox
$77.76 /

+13.45 (+20.91%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

LB L Brands
$67.58 /

-1.24 (-1.80%)

JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

DDD 3D Systems
$24.02 /

+6.21 (+34.87%)

WYNN Wynn Resorts
$124.95 /

-0.76 (-0.60%)

SPCE Virgin Galactic
$18.12 /

+0.15 (+0.83%)

RXT Rackspace Technology
$19.02 /

-5.05 (-20.98%)

RBLX Roblox
$77.76 /

+13.45 (+20.91%)

PLTR Palantir
$20.21 /

+1.74 (+9.42%)

PFE Pfizer
$39.34 /

-0.53 (-1.33%)

NNOX Nano-X Imaging
$21.29 /

-4.87 (-18.62%)

NLOK NortonLifeLock
$23.35 /

+2.27 (+10.77%)

LB L Brands
$67.58 /

-1.24 (-1.80%)

JNJ Johnson & Johnson
$168.82 /

-1.62 (-0.95%)

DDD 3D Systems
$24.02 /

+6.21 (+34.87%)

BNTX BioNTech
$198.60 /

-3.93 (-1.94%)

Periodicals
White House tells states no J&J vaccine next week, Politico reports » 14:24
05/11/21
05/11
14:24
05/11/21
14:24
JNJ

Johnson & Johnson

$168.58 /

-1.86 (-1.09%)

White House officials…

White House officials told governors on a private call today that new supply of Johnson & Johnson's Covid vaccine wasn't immediately available for next week, Rachel Roubein of Politico reports. It is not immediately clear whether the federal government would ship out J&J doses through federal distribution channels, such as those for pharmacy chains and community health centers, added Roubein. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

JNJ Johnson & Johnson
$168.58 /

-1.86 (-1.09%)

Conference/Events
BofA to hold a virtual conference » 09:36
05/11/21
05/11
09:36
05/11/21
09:36
ADCT

ADC Therapeutics

$22.44 /

-1.15 (-4.87%)

, ADMS

Adamas Pharmaceuticals

$4.96 /

-0.2 (-3.88%)

, AVTR

Avantor

$30.48 /

-0.725 (-2.32%)

, CCRN

Cross Country Healthcare

$17.16 /

+0.26 (+1.54%)

, FIXX

Homology Medicines

$6.39 /

-0.13 (-1.99%)

, IMTX

Immatics

$10.81 /

-0.77 (-6.65%)

, ISRG

Intuitive Surgical

$835.60 /

-21.9 (-2.55%)

, ITCI

Intra-Cellular

$35.97 /

+1.01 (+2.89%)

, JAZZ

Jazz Pharmaceuticals

$176.02 /

+1.35 (+0.77%)

, JNJ

Johnson & Johnson

$170.32 /

+1.68 (+1.00%)

, LLY

Eli Lilly

$194.82 /

-0.75 (-0.38%)

, TVTX

Travere Therapeutics

$19.78 /

-0.23 (-1.15%)

, QGEN

Qiagen

$46.90 /

-0.75 (-1.57%)

, PTCT

PTC Therapeutics

$38.88 /

-1.34 (-3.33%)

, PHG

Philips

$56.39 /

-1.016893 (-1.77%)

, SWAV

ShockWave Medical

$134.82 /

-12.73 (-8.63%)

, RLAY

Relay Therapeutics

$27.69 /

-1.8 (-6.10%)

, ZBH

Zimmer Biomet

$171.99 /

-0.575 (-0.33%)

, WST

West Pharmaceutical

$333.76 /

-0.36 (-0.11%)

, NVRO

Nevro

$155.00 /

-1.15 (-0.74%)

, HUM

Humana

$470.07 /

+5.45 (+1.17%)

, DHR

Danaher

$259.10 /

+0.8 (+0.31%)

Bank of America Merrill…

Bank of America Merrill Lynch Virtual Healthcare Conference will be held on May 11-13.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$171.99 /

-0.575 (-0.33%)

TVTX Travere Therapeutics
$19.78 /

-0.23 (-1.15%)

SWAV ShockWave Medical
$134.82 /

-12.73 (-8.63%)

RLAY Relay Therapeutics
$27.69 /

-1.8 (-6.10%)

QGEN Qiagen
$46.90 /

-0.75 (-1.57%)

PTCT PTC Therapeutics
$38.88 /

-1.34 (-3.33%)

PHG Philips
$56.39 /

-1.016893 (-1.77%)

NVRO Nevro
$155.00 /

-1.15 (-0.74%)

LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

JAZZ Jazz Pharmaceuticals
$176.02 /

+1.35 (+0.77%)

ITCI Intra-Cellular
$35.97 /

+1.01 (+2.89%)

ISRG Intuitive Surgical
$835.60 /

-21.9 (-2.55%)

IMTX Immatics
$10.81 /

-0.77 (-6.65%)

HUM Humana
$470.07 /

+5.45 (+1.17%)

FIXX Homology Medicines
$6.39 /

-0.13 (-1.99%)

DHR Danaher
$259.10 /

+0.8 (+0.31%)

CCRN Cross Country Healthcare
$17.16 /

+0.26 (+1.54%)

AVTR Avantor
$30.48 /

-0.725 (-2.32%)

ADMS Adamas Pharmaceuticals
$4.96 /

-0.2 (-3.88%)

ADCT ADC Therapeutics
$22.44 /

-1.15 (-4.87%)

ADCT ADC Therapeutics
$22.44 /

-1.15 (-4.87%)

04/26/21 H.C. Wainwright
ADC Therapeutics price target raised to $57 from $48 at H.C. Wainwright
03/19/21 H.C. Wainwright
ADC Therapeutics price target raised to $48 from $47 at H.C. Wainwright
12/02/20 Stifel
ADC Therapeutics initiated with a Hold at Stifel
10/29/20
Fly Intel: Top five analyst initiations
ADMS Adamas Pharmaceuticals
$4.96 /

-0.2 (-3.88%)

02/02/21 H.C. Wainwright
Adamas Pharmaceuticals price target raised to $12 from $10 at H.C. Wainwright
02/01/21 JMP Securities
Adamas settlement brings 'robust' patent exclusivity, says JMP Securities
01/28/21 Northland
Adamas Pharmaceuticals price target raised to $12.50 from $7.50 at Northland
AVTR Avantor
$30.48 /

-0.725 (-2.32%)

04/29/21 JPMorgan
Avantor price target raised to $40 from $35 at JPMorgan
04/29/21 Baird
Avantor price target raised to $36 from $32 at Baird
04/29/21 Stifel
Avantor upgraded to Buy after 'strong' Q1 report at Stifel
04/29/21 Stifel
Avantor upgraded to Buy from Hold at Stifel
CCRN Cross Country Healthcare
$17.16 /

+0.26 (+1.54%)

05/06/21 Benchmark
Cross Country Healthcare downgraded to Hold from Buy at Benchmark
03/09/21 Barrington
Barrington ups Cross Country Healthcare target to $14 after quarterly results
11/25/20 Barrington
Cross Country Healthcare target raised to $12 at Barrington after Q3 results
11/23/20 BMO Capital
BMO upgrades Cross Country Healthcare to Outperform on success of turnaround
FIXX Homology Medicines
$6.39 /

-0.13 (-1.99%)

05/07/21 Oppenheimer
Homology Medicines price target lowered to $24 from $27 at Oppenheimer
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
03/01/21 Stifel
Homology Medicines initiated with a Hold at Stifel
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
IMTX Immatics
$10.81 /

-0.77 (-6.65%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
11/20/20 BofA
Immatics initiated with a Buy at BofA
09/21/20 Goldman Sachs
Immatics initiated with a Buy at Goldman Sachs
ISRG Intuitive Surgical
$835.60 /

-21.9 (-2.55%)

04/21/21 SVB Leerink
Intuitive Surgical price target raised to $860 from $825 at SVB Leerink
04/21/21 Wells Fargo
Intuitive Surgical price target raised to $892 from $879 at Wells Fargo
04/21/21 Deutsche Bank
Intuitive Surgical price target raised to $825 from $690 at Deutsche Bank
04/21/21 JPMorgan
Intuitive Surgical price target raised to $900 from $840 at JPMorgan
ITCI Intra-Cellular
$35.97 /

+1.01 (+2.89%)

12/29/20 Cantor Fitzgerald
Intra-Cellular price target raised to $54 from $53 at Cantor Fitzgerald
12/15/20
Fly Intel: Top five analyst initiations
12/15/20 BofA
Intra-Cellular initiated with a Buy at BofA
12/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$176.02 /

+1.35 (+0.77%)

04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
04/14/21 Stifel
Jazz Pharmaceuticals price target raised to $202 from $195 at Stifel
04/06/21 RBC Capital
Jazz Pharmaceuticals transferred with an Outperform at RBC Capital
04/01/21 Morgan Stanley
Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley
JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
TVTX Travere Therapeutics
$19.78 /

-0.23 (-1.15%)

05/07/21 BMO Capital
Travere Therapeutics price target lowered to $38 from $43 at BMO Capital
04/12/21 Wedbush
Travere Therapeutics price target lowered to $39 from $46 at Wedbush
03/02/21 BMO Capital
Travere Therapeutics price target lowered to $43 from $48 at BMO Capital
02/16/21 Barclays
Travere Therapeutics assumed with an Overweight at Barclays
QGEN Qiagen
$46.90 /

-0.75 (-1.57%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
PTCT PTC Therapeutics
$38.88 /

-1.34 (-3.33%)

04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
PHG Philips
$56.39 /

-1.016893 (-1.77%)

04/29/21 Berenberg
Philips price target raised to EUR 52 from EUR 50 at Berenberg
04/28/21 Credit Suisse
Philips price target raised to EUR 49 from EUR 45 at Credit Suisse
04/27/21 UBS
Philips price target raised to EUR 56 from EUR 54 at UBS
03/23/21 Barclays
Philips price target raised to EUR 55 from EUR 54 at Barclays
SWAV ShockWave Medical
$134.82 /

-12.73 (-8.63%)

05/11/21 Wells Fargo
ShockWave Medical price target raised to $161 from $151 at Wells Fargo
05/11/21 BofA
ShockWave Medical upgraded to Buy at BofA after guidance hike
05/11/21 BofA
ShockWave Medical upgraded to Buy from Neutral at BofA
05/11/21 Piper Sandler
ShockWave Medical upgraded to Overweight from Neutral at Piper Sandler
RLAY Relay Therapeutics
$27.69 /

-1.8 (-6.10%)

03/29/21 JMP Securities
Relay Therapeutics price target lowered to $50 from $66 at JMP Securities
01/29/21 JPMorgan
Relay Therapeutics price target raised to $52 from $36 at JPMorgan
12/15/20 H.C. Wainwright
Relay Therapeutics price target raised to $57 from $54 at H.C. Wainwright
12/08/20 JMP Securities
Relay Therapeutics initiated with an Outperform at JMP Securities
ZBH Zimmer Biomet
$171.99 /

-0.575 (-0.33%)

05/11/21 JMP Securities
Zimmer Biomet price target raised to $195 from $180 at JMP Securities
05/05/21 Truist
Zimmer Biomet price target raised to $188 from $174 at Truist
05/05/21 Oppenheimer
Zimmer Biomet price target raised to $195 from $185 at Oppenheimer
04/09/21 Northland
Zimmer Biomet upgraded to Outperform from Market Perform at Northland
WST West Pharmaceutical
$333.76 /

-0.36 (-0.11%)

11/09/20 KeyBanc
West Pharmaceutical initiated with an Overweight at KeyBanc
10/13/20 Stephens
West Pharmaceutical initiated with an Equal Weight at Stephens
07/21/20 BofA
West Pharmaceutical upgraded to Buy on COVID-related tailwinds at BofA
07/21/20 BofA
West Pharmaceutical upgraded to Buy from Neutral at BofA
NVRO Nevro
$155.00 /

-1.15 (-0.74%)

05/06/21 Canaccord
Nevro price target raised to $225 from $217 at Canaccord
04/05/21 Piper Sandler
Nevro publication in JAMA Neurology helps add credibility, says Piper Sandler
02/25/21 Canaccord
Nevro price target raised to $217 from $203 at Canaccord
02/02/21
Fly Intel: Top five analyst initiations
HUM Humana
$470.07 /

+5.45 (+1.17%)

04/29/21 Oppenheimer
Humana price target raised to $480 from $460 at Oppenheimer
04/29/21 Mizuho
Humana price target raised to $480 from $462 at Mizuho
04/29/21 Citi
Humana price target raised to $510 from $496 at Citi
04/16/21 Stephens
Humana named a new Best Idea for 2021 at Stephens
DHR Danaher
$259.10 /

+0.8 (+0.31%)

04/26/21 Barclays
Danaher price target raised to $300 from $265 at Barclays
04/23/21 Jefferies
Danaher price target raised to $290 from $270 at Jefferies
04/23/21 Baird
Danaher price target raised to $270 from $249 at Baird
04/23/21 Wells Fargo
Danaher price target raised to $280 from $260 at Wells Fargo
ZBH Zimmer Biomet
$171.99 /

-0.575 (-0.33%)

WST West Pharmaceutical
$333.76 /

-0.36 (-0.11%)

TVTX Travere Therapeutics
$19.78 /

-0.23 (-1.15%)

SWAV ShockWave Medical
$134.82 /

-12.73 (-8.63%)

RLAY Relay Therapeutics
$27.69 /

-1.8 (-6.10%)

QGEN Qiagen
$46.90 /

-0.75 (-1.57%)

PTCT PTC Therapeutics
$38.88 /

-1.34 (-3.33%)

PHG Philips
$56.39 /

-1.016893 (-1.77%)

NVRO Nevro
$155.00 /

-1.15 (-0.74%)

LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

JAZZ Jazz Pharmaceuticals
$176.02 /

+1.35 (+0.77%)

ITCI Intra-Cellular
$35.97 /

+1.01 (+2.89%)

ISRG Intuitive Surgical
$835.60 /

-21.9 (-2.55%)

IMTX Immatics
$10.81 /

-0.77 (-6.65%)

HUM Humana
$470.07 /

+5.45 (+1.17%)

FIXX Homology Medicines
$6.39 /

-0.13 (-1.99%)

DHR Danaher
$259.10 /

+0.8 (+0.31%)

CCRN Cross Country Healthcare
$17.16 /

+0.26 (+1.54%)

AVTR Avantor
$30.48 /

-0.725 (-2.32%)

ADMS Adamas Pharmaceuticals
$4.96 /

-0.2 (-3.88%)

ADCT ADC Therapeutics
$22.44 /

-1.15 (-4.87%)

  • 07
    Apr
  • 25
    Feb
  • 12
    Feb
  • 06
    Nov
  • 24
    Sep
  • 11
    Sep
  • 20
    Aug
  • 16
    Jul
  • 17
    Jun
  • 21
    May
  • 15
    May
QGEN Qiagen
$46.90 /

-0.75 (-1.57%)

PHG Philips
$56.39 /

-1.016893 (-1.77%)

NVRO Nevro
$155.00 /

-1.15 (-0.74%)

LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

JAZZ Jazz Pharmaceuticals
$176.02 /

+1.35 (+0.77%)

DHR Danaher
$259.10 /

+0.8 (+0.31%)

ZBH Zimmer Biomet
$171.99 /

-0.575 (-0.33%)

SWAV ShockWave Medical
$134.82 /

-12.73 (-8.63%)

QGEN Qiagen
$46.90 /

-0.75 (-1.57%)

PTCT PTC Therapeutics
$38.88 /

-1.34 (-3.33%)

PHG Philips
$56.39 /

-1.016893 (-1.77%)

LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

JAZZ Jazz Pharmaceuticals
$176.02 /

+1.35 (+0.77%)

ISRG Intuitive Surgical
$835.60 /

-21.9 (-2.55%)

IMTX Immatics
$10.81 /

-0.77 (-6.65%)

HUM Humana
$470.07 /

+5.45 (+1.17%)

FIXX Homology Medicines
$6.39 /

-0.13 (-1.99%)

CCRN Cross Country Healthcare
$17.16 /

+0.26 (+1.54%)

ZBH Zimmer Biomet
$171.99 /

-0.575 (-0.33%)

TVTX Travere Therapeutics
$19.78 /

-0.23 (-1.15%)

RLAY Relay Therapeutics
$27.69 /

-1.8 (-6.10%)

LLY Eli Lilly
$194.82 /

-0.75 (-0.38%)

JNJ Johnson & Johnson
$170.32 /

+1.68 (+1.00%)

ISRG Intuitive Surgical
$835.60 /

-21.9 (-2.55%)

DHR Danaher
$259.10 /

+0.8 (+0.31%)

Monday
Hot Stocks
FDA to hold advisory committee meeting on pediatric COVID vaccine use on June 10 » 12:24
05/10/21
05/10
12:24
05/10/21
12:24
PFE

Pfizer

$40.11 /

+0.54 (+1.36%)

, BNTX

BioNTech

$197.44 /

+13.87 (+7.56%)

, MRNA

Moderna

$158.63 /

-4.51 (-2.76%)

, AZN

AstraZeneca

$54.58 /

+0.78 (+1.45%)

, JNJ

Johnson & Johnson

$170.66 /

+2.02 (+1.20%)

, NVAX

Novavax

$166.90 /

-8.72 (-4.97%)

, INO

Inovio

$6.98 /

+0.14 (+2.05%)

The U.S. Food and Drug…

The U.S. Food and Drug Administration's Center for Biologics Evaluation and Research will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10, 2021, via webcast, to provide a status update on its approach to emergency use authorization for COVID-19 vaccines intended for use in individuals 12 through 17 years of age. The committee will also discuss the data needed to support an EUA and a biologics license application for a COVID-19 vaccine intended for use in children less than 12 years of age. "The committee will not discuss any specific products," the FDA stated. Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, said: "Vaccines continue to be an important public health measure in fighting the COVID-19 pandemic. To date, the FDA has authorized three COVID-19 vaccines for emergency use that have met our rigorous standards for quality, safety, and effectiveness - two are authorized for individuals 18 and older, and one is authorized for individuals 16 and older. We recognize that the next critical step is having vaccines available for use throughout the pediatric population. As with the initial COVID-19 vaccine authorizations, we want to ensure that the public has a clear understanding of our expectations for the data and information needed to support requests for emergency use authorization and biologics license applications for vaccines intended to prevent COVID-19 in this pediatric age range." Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Inovio (INO), Vaxart (VXRT) and CureVac (CVAC). Reference Link

ShowHide Related Items >><<
PFE Pfizer
$40.11 /

+0.54 (+1.36%)

NVAX Novavax
$166.90 /

-8.72 (-4.97%)

MRNA Moderna
$158.63 /

-4.51 (-2.76%)

JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

INO Inovio
$6.98 /

+0.14 (+2.05%)

BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

AZN AstraZeneca
$54.58 /

+0.78 (+1.45%)

PFE Pfizer
$40.11 /

+0.54 (+1.36%)

05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
MRNA Moderna
$158.63 /

-4.51 (-2.76%)

05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
05/06/21 Needham
Moderna execution 'continues to impress,' but reflected in stock, says Needham
AZN AstraZeneca
$54.58 /

+0.78 (+1.45%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$166.90 /

-8.72 (-4.97%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
INO Inovio
$6.98 /

+0.14 (+2.05%)

05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
04/23/21 Piper Sandler
Piper 'incrementally cautious' on Inovio, says today's selloff appropriate
PFE Pfizer
$40.11 /

+0.54 (+1.36%)

NVAX Novavax
$166.90 /

-8.72 (-4.97%)

MRNA Moderna
$158.63 /

-4.51 (-2.76%)

JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

INO Inovio
$6.98 /

+0.14 (+2.05%)

BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

AZN AstraZeneca
$54.58 /

+0.78 (+1.45%)

  • 21
    Jan
  • 23
    Jul
  • 19
    May
PFE Pfizer
$40.11 /

+0.54 (+1.36%)

NVAX Novavax
$166.90 /

-8.72 (-4.97%)

JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

PFE Pfizer
$40.11 /

+0.54 (+1.36%)

NVAX Novavax
$166.90 /

-8.72 (-4.97%)

MRNA Moderna
$158.63 /

-4.51 (-2.76%)

JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

INO Inovio
$6.98 /

+0.14 (+2.05%)

BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

AZN AstraZeneca
$54.58 /

+0.78 (+1.45%)

PFE Pfizer
$40.11 /

+0.54 (+1.36%)

NVAX Novavax
$166.90 /

-8.72 (-4.97%)

MRNA Moderna
$158.63 /

-4.51 (-2.76%)

JNJ Johnson & Johnson
$170.66 /

+2.02 (+1.20%)

INO Inovio
$6.98 /

+0.14 (+2.05%)

BNTX BioNTech
$197.44 /

+13.87 (+7.56%)

AZN AstraZeneca
$54.58 /

+0.78 (+1.45%)

Over a week ago
On The Fly
Moderna, Pfizer slip despite stronger results as U.S. backs vaccine IP waiver » 14:30
05/06/21
05/06
14:30
05/06/21
14:30
MRNA

Moderna

$160.79 /

-1.89 (-1.16%)

, PFE

Pfizer

$38.91 /

-0.67 (-1.69%)

, BNTX

BioNTech

$170.34 /

-0.34 (-0.20%)

, AZN

AstraZeneca

$53.14 /

-0.48 (-0.90%)

, JNJ

Johnson & Johnson

$166.93 /

-0.16 (-0.10%)

, NVAX

Novavax

$175.00 /

+3.02 (+1.76%)

, VXRT

Vaxart

$6.88 /

-0.485 (-6.59%)

, CVAC

CureVac

$93.63 /

-7.39 (-7.32%)

While both Moderna (MRNA)…

ShowHide Related Items >><<
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.91 /

-0.67 (-1.69%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$175.00 /

+3.02 (+1.76%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
CVAC CureVac
$93.63 /

-7.39 (-7.32%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

VXRT Vaxart
$6.88 /

-0.485 (-6.59%)

PFE Pfizer
$38.91 /

-0.67 (-1.69%)

NVAX Novavax
$175.00 /

+3.02 (+1.76%)

MRNA Moderna
$160.79 /

-1.89 (-1.16%)

JNJ Johnson & Johnson
$166.93 /

-0.16 (-0.10%)

CVAC CureVac
$93.63 /

-7.39 (-7.32%)

BNTX BioNTech
$170.34 /

-0.34 (-0.20%)

AZN AstraZeneca
$53.14 /

-0.48 (-0.90%)

Periodicals
Germany's Merkel opposed to vaccine patent waivers, Bloomberg reports » 12:14
05/06/21
05/06
12:14
05/06/21
12:14
MRNA

Moderna

$156.69 /

-5.99 (-3.68%)

, PFE

Pfizer

$38.89 /

-0.69 (-1.74%)

, BNTX

BioNTech

$164.18 /

-6.5 (-3.81%)

, AZN

AstraZeneca

$53.16 /

-0.46 (-0.86%)

, JNJ

Johnson & Johnson

$166.87 /

-0.22 (-0.13%)

, NVAX

Novavax

$168.55 /

-3.43 (-1.99%)

, CVAC

CureVac

$93.30 /

-7.72 (-7.64%)

, VXRT

Vaxart

$6.60 /

-0.765 (-10.39%)

German Chancellor Angela…

German Chancellor Angela Merkel is opposed to a U.S. proposal to waive patent protections for COVID-19 vaccines, stating that such a plan would create "severe complications" for the production of vaccines, reported Bloomberg, citing a German government spokeswoman. Without a profit incentive, drugmakers might not move as aggressively to make vaccines, the industry has argued. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Vaxart (VXRT) and CureVac (CVAC). Reference Link

ShowHide Related Items >><<
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$168.55 /

-3.43 (-1.99%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
CVAC CureVac
$93.30 /

-7.72 (-7.64%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

VXRT Vaxart
$6.60 /

-0.765 (-10.39%)

PFE Pfizer
$38.89 /

-0.69 (-1.74%)

NVAX Novavax
$168.55 /

-3.43 (-1.99%)

MRNA Moderna
$156.69 /

-5.99 (-3.68%)

JNJ Johnson & Johnson
$166.87 /

-0.22 (-0.13%)

CVAC CureVac
$93.30 /

-7.72 (-7.64%)

BNTX BioNTech
$164.18 /

-6.5 (-3.81%)

AZN AstraZeneca
$53.16 /

-0.46 (-0.86%)

Periodicals
Merkel opposes plan to waive COVID vaccine patent protection, Bloomberg says » 11:25
05/06/21
05/06
11:25
05/06/21
11:25
MRNA

Moderna

$148.75 /

-13.93 (-8.56%)

, PFE

Pfizer

$38.52 /

-1.06 (-2.68%)

, BNTX

BioNTech

$159.00 /

-11.68 (-6.84%)

, AZN

AstraZeneca

$53.02 /

-0.6 (-1.12%)

, JNJ

Johnson & Johnson

$166.44 /

-0.65 (-0.39%)

, NVAX

Novavax

$163.78 /

-8.2 (-4.77%)

, CVAC

CureVac

$90.08 /

-10.94 (-10.83%)

, VXRT

Vaxart

$6.41 /

-0.955 (-12.97%)

Bloomberg cites a German…

Bloomberg cites a German government spokesperson as saying that the U.S. plan would create "severe complications" for the production of vaccines. Companies with approved COVID-19 vaccines or working on such vaccines include Pfizer (PFE), BioNTech (BNTX), Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Novavax (NVAX), Vaxart (VXRT) and CureVac (CVAC).

ShowHide Related Items >><<
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
PFE Pfizer
$38.52 /

-1.06 (-2.68%)

05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
NVAX Novavax
$163.78 /

-8.2 (-4.77%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
CVAC CureVac
$90.08 /

-10.94 (-10.83%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

03/04/21 B. Riley
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

  • 28
    Jan
  • 14
    Aug
  • 23
    Jul
  • 19
    May
PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

VXRT Vaxart
$6.41 /

-0.955 (-12.97%)

PFE Pfizer
$38.52 /

-1.06 (-2.68%)

NVAX Novavax
$163.78 /

-8.2 (-4.77%)

MRNA Moderna
$148.75 /

-13.93 (-8.56%)

JNJ Johnson & Johnson
$166.44 /

-0.65 (-0.39%)

CVAC CureVac
$90.08 /

-10.94 (-10.83%)

BNTX BioNTech
$159.00 /

-11.68 (-6.84%)

AZN AstraZeneca
$53.02 /

-0.6 (-1.12%)

On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:23
05/05/21
05/05
17:23
05/05/21
17:23
GM

General Motors

$57.56 /

+2.215 (+4.00%)

, LYFT

Lyft

$52.61 /

-3.56 (-6.34%)

, TMUS

T-Mobile

$134.14 /

+5.43 (+4.22%)

, FB

Facebook

$315.06 /

-3.54 (-1.11%)

, PTON

Peloton

$82.61 /

-14.26 (-14.72%)

, HNST

Honest Company

$22.95 /

+1.65 (+7.75%)

, PFE

Pfizer

$39.97 /

+ (+0.00%)

, BNTX

BioNTech

$170.68 /

-6.22 (-3.52%)

, GME

GameStop

$159.40 /

-1.6 (-0.99%)

, ATNX

Athenex

$4.57 /

+0.85 (+22.85%)

, HAYW

Hayward

$24.15 /

+4.755 (+24.52%)

, HFC

HollyFrontier

$34.69 /

-1.57 (-4.33%)

, ESPR

Esperion

$20.01 /

-5.585 (-21.82%)

, RDS.A

Royal Dutch Shell

$39.80 /

+1.16 (+3.00%)

, RDS.B

Royal Dutch Shell

$37.47 /

+1.26 (+3.48%)

, MRNA

Moderna

$162.64 /

-11.025 (-6.35%)

, JNJ

Johnson & Johnson

$167.09 /

-0.67 (-0.40%)

The major averages were…

ShowHide Related Items >><<
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

05/06/21 Deutsche Bank
General Motors price target raised to $70 from $67 at Deutsche Bank
05/06/21 RBC Capital
General Motors price target raised to $72 from $67 at RBC Capital
05/06/21 Barclays
General Motors price target raised to $66 from $64 at Barclays
04/22/21 Wolfe Research
Wolfe upgrades Ford with $15 target, sees GM-like 'significant re-rating'
LYFT Lyft
$52.61 /

-3.56 (-6.34%)

05/06/21 Citi
Lyft price target raised to $80 from $76 at Citi
05/06/21 Piper Sandler
Uber price target lowered to $55 from $58 at Piper Sandler
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
05/05/21 DA Davidson
Lyft price target raised to $72 from $66 at DA Davidson
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

04/26/21 Oppenheimer
Crown Castle price target raised to $205 from $170 at Oppenheimer
04/19/21 Deutsche Bank
T-Mobile price target raised to $185 from $155 at Deutsche Bank
03/30/21 KeyBanc
KeyBanc sees partnership with Google as neutral to T-Mobile
03/12/21 Morgan Stanley
T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
FB Facebook
$315.06 /

-3.54 (-1.11%)

04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
04/29/21 Truist
Facebook price target raised to $400 from $350 at Truist
04/29/21 Wedbush
Facebook price target raised to $355 from $340 at Wedbush
04/29/21 Canaccord
Facebook price target raised to $380 from $350 at Canaccord
PTON Peloton
$82.61 /

-14.26 (-14.72%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
HNST Honest Company
$22.95 /

+1.65 (+7.75%)

PFE Pfizer
$39.97 /

+ (+0.00%)

05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
GME GameStop
$159.40 /

-1.6 (-0.99%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
ATNX Athenex
$4.57 /

+0.85 (+22.85%)

03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/02/21 Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
03/02/21 Truist
Athenex downgraded to Hold from Buy at Truist
HAYW Hayward
$24.15 /

+4.755 (+24.52%)

05/06/21 KeyBanc
Hayward price target raised to $28 from $21 at KeyBanc
05/06/21 Morgan Stanley
Hayward price target raised to $27 from $19 at Morgan Stanley
05/06/21 Baird
Hayward price target raised to $28 from $20 at Baird
04/06/21 Jefferies
Hayward initiated with a Buy at Jefferies
HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

04/01/21 Piper Sandler
HollyFrontier price target raised to $45 from $35 at Piper Sandler
03/17/21 US Capital Advisors
HollyFrontier downgraded to Hold from Overweight at US Capital Advisors
03/08/21 Barclays
HollyFrontier price target raised to $38 from $35 at Barclays
02/26/21 Mizuho
HollyFrontier price target raised to $40 from $25 at Mizuho
ESPR Esperion
$20.01 /

-5.585 (-21.82%)

05/05/21 BTIG
Esperion price target lowered to $71 from $90 at BTIG
05/05/21 Northland
Esperion price target lowered to $24 from $30 at Northland
05/05/21 Credit Suisse
Esperion price target lowered to $36 from $45 at Credit Suisse
05/05/21 Stifel
Stifel downgrades Esperion to Hold with bull case seen 'off the table'
RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
04/01/21 Piper Sandler
Royal Dutch Shell price target raised to $55 from $48 at Piper Sandler
RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
MRNA Moderna
$162.64 /

-11.025 (-6.35%)

05/05/21 Jefferies
Jefferies says COVID vaccine availability a supply-chain issue
05/03/21 Piper Sandler
Piper reiterates $234 target on Moderna after WHO Emergency Use Listing
04/29/21 Piper Sandler
Piper keeps $234 target on Moderna after raised Covid vaccine guidance
04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

  • 05
    May
  • 12
    Mar
  • 10
    Sep
  • 23
    Jul
  • 24
    Jun
  • 19
    May
TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

RDS.B Royal Dutch Shell
$37.47 /

+1.26 (+3.48%)

RDS.A Royal Dutch Shell
$39.80 /

+1.16 (+3.00%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HNST Honest Company
$22.95 /

+1.65 (+7.75%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

ESPR Esperion
$20.01 /

-5.585 (-21.82%)

ATNX Athenex
$4.57 /

+0.85 (+22.85%)

TMUS T-Mobile
$134.14 /

+5.43 (+4.22%)

PTON Peloton
$82.61 /

-14.26 (-14.72%)

PFE Pfizer
$39.97 /

+ (+0.00%)

MRNA Moderna
$162.64 /

-11.025 (-6.35%)

LYFT Lyft
$52.61 /

-3.56 (-6.34%)

JNJ Johnson & Johnson
$167.09 /

-0.67 (-0.40%)

HFC HollyFrontier
$34.69 /

-1.57 (-4.33%)

HAYW Hayward
$24.15 /

+4.755 (+24.52%)

GME GameStop
$159.40 /

-1.6 (-0.99%)

GM General Motors
$57.56 /

+2.215 (+4.00%)

FB Facebook
$315.06 /

-3.54 (-1.11%)

BNTX BioNTech
$170.68 /

-6.22 (-3.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.